Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 424B1 Offering Prospectus
  2. 10-Q/A Report 10-Q/A
  3. 10-Q Report Quarterly Report
  4. S-3 Offering Registration Statement
  5. 8-K Event Item 5 · Item 7
  6. 10-Q Report Quarterly Report
  7. DEF 14A Proxy Proxy Statement
  8. 10-K405 Other 10-K405
  9. 8-K Event Item 2 · Item 7
  10. S-3/A Offering Registration Statement
  11. DEL AM Other DEL AM
  12. 10-Q Report Quarterly Report
  13. S-3 Offering Registration Statement
  14. 10-Q Report Quarterly Report
  15. 8-K Event Item 5 · Item 7
  16. 10-Q Report Quarterly Report
  17. 8-K Event Item 5 · Item 7
  18. DEF 14A Proxy Proxy Statement

Page 65 of 65 · 1,298 filings